-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Navidea Biopharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2016 to Q3 2023.
- Navidea Biopharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2023 was -0.02 USD/shares, a 92% increase year-over-year.
- Navidea Biopharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -0.06 USD/shares, a 89.5% increase year-over-year.
- Navidea Biopharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -0.56 USD/shares, a 40% decline from 2021.
- Navidea Biopharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -0.4 USD/shares.
- Navidea Biopharmaceuticals, Inc. annual Earnings Per Share, Basic for 2018 was -0.09 USD/shares, a 119% decline from 2017.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)